Bovogen Biologicals was established in 2001 and commenced manufacturing Bovine Serum Albumin (BSA) on a commercial scale in 2003. With the natural transition to manufacturing other specialty protein products, Bovogen in 2009 diversified its focus towards process development, manufacturing and sterile filtration of animal serums.
In late 2016, ANZCO Foods of New Zealand acquired Bovogen Biologicals Pty Ltd, completing a vertical integration initiative for its global Healthcare business. This opportunity provided ANZCO Foods a complete alignment capability with respect to material sourcing / supply, processing, manufacture and production of animal derived serums and specialty proteins. The opportunity created for Bovogen Biologicals via this acquisition is the access to a consistent supply of high quality controlled raw materials (serum and plasma), long term supply guarantee of quality tested material (plasma and serum) and the ability to deliver real time fully traceable lines of material (plasma and serum) to customers wanting origin proof and animal tracelibility.
ANZCO Foods is a vertically integrated beef/lamb marketing company that was established in Japan in 1984, with its Head Office located in Christchurch; New Zealand. The ANZCO Healthcare division is an innovative business unit established to develop opportunities via creating value added by-products. Some of these category applications include; medical bio-tissues, medical and veterinary bio-culture product, human and animal nutrition ingredients / foods, cosmetic and healthcare ingredients and other specialty uses. Our success in applied innovation has seen significant progress and achievement via the collaboration with industry specialists and global leading companies.
ANZCO Foods is 100 percent owned by Itoham Foods (Mitsubishi Corporation as major shareholder) of Japan. It is New Zealand’s fifth largest exporting company, and has more than three thousand employees and eight international offices.
To be a leading global manufacturer of specialised biological ingredients for the biopharmaceutical sector
To guarantee our product quality meets and / or exceeds our specifications
To surpass customer expectations for quality, product delivery and service
To foster a culture around partnering with our customers
Our vertical integration and sourcing capabilities of Australian and New Zealand animal sera and tissues
Our ability to meet global quality standards and certification benchmarks
Our commitment to collaborate and build long term strategic partnerships
Our honest, trusting and ethical business approach